{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:43:40Z","timestamp":1790981020178,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,4,1]]},"abstract":"<jats:p>The p21 is a downstream effector of p53\/p73 and belongs to the CIP\/KIP family of cyclin-dependent kinase inhibitors (CDKIs). It is, therefore, a potential tumor suppressor gene and probably plays an important role in tumor development. Moreover, reduced expression of p21 has been reported to have prognostic value in several human malignancies. In contrast with other CDKIs, mutational inactivation of p21 is infrequent, but gene inactivation by an alternative mechanism seems to be the general pathway. In this study, we analyzed the methylation status of the p21 promoter region using semiquantitative polymerase chain reaction in 124 patients with acute lymphoblastic leukemia (ALL). We observed p21 hypermethylation in bone marrow cells from 41% (51 of 124) of ALL patients. Hypermethylation within promoter strongly correlated with decreased p21 messenger RNA expression in tumoral cells. Clinical, molecular, and laboratory features and complete remission rate did not differ significantly between hypermethylated and normally methylated patients. Estimated disease-free survival (DFS) and overall survival at 7 and 9 years, respectively, were 59% and 65% for healthy patients and 6% and 8% for hypermethylated patients (P\u2009=\u2009.00001 andP\u2009=\u2009.006). Multivariate analysis of potential prognostic factors demonstrated that p21 methylation status was an independent prognostic factor in predicting DFS (P\u2009=\u2009.0001). Our results indicate that the p21 gene is subject to methylation regulation at the transcription level in ALL and seems to be an important factor in predicting the clinical outcome of these patients.<\/jats:p>","DOI":"10.1182\/blood.v99.7.2291","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"2291-2296","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":151,"title":["5\u2032 CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1\/WAF1\/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"99","author":[{"given":"Jose","family":"Roman-Gomez","sequence":"first","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Castillejo","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Jimenez","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gracia","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Moreno","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Carmen","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Barrios","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Maldonado","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Torres","sequence":"additional","affiliation":[{"name":"From the Hematology Department, Reina Sofia Hospital, Cordoba, Spain, and the Hematology Department, Carlos Haya Hospital, Malaga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222112038400_B1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1 phase progression.","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"2020021222112038400_B2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(93)90528-X","article-title":"Braking the cell cycle.","volume":"75","author":"Hunter","year":"1993","journal-title":"Cell."},{"key":"2020021222112038400_B3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V86.3.841.841","article-title":"Role of the cyclin-dependent kinase inhibitors in the development of cancer.","volume":"86","author":"Hirama","year":"1995","journal-title":"Blood."},{"key":"2020021222112038400_B4","first-page":"1169","article-title":"WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis.","volume":"54","author":"el-Deiry","year":"1994","journal-title":"Cancer Res."},{"key":"2020021222112038400_B5","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood.V93.12.4167","article-title":"Expression of p21cip21\/waf1\/sdi1 and p27kip1 cyclin-dependent kinase inhibitors during human hematopoiesis.","volume":"93","author":"Taniguchi","year":"1999","journal-title":"Blood."},{"key":"2020021222112038400_B6","first-page":"4536","article-title":"Tumor suppression by p21WAF1.","volume":"55","author":"Chen","year":"1995","journal-title":"Cancer Res."},{"key":"2020021222112038400_B7","first-page":"2387","article-title":"Relationships between G1 arrest and stability of the p53 and p21cip1\/waf1 proteins following \u03b3-irradiation of human lymphoma cells.","volume":"55","author":"Bae","year":"1995","journal-title":"Cancer Res."},{"key":"2020021222112038400_B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia.","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med."},{"key":"2020021222112038400_B9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V82.2.343.343","article-title":"Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.","volume":"82","author":"Pui","year":"1993","journal-title":"Blood."},{"key":"2020021222112038400_B10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI117806","article-title":"Posttranscriptional stabilization underlies p53-independent induction of p21 WAF1\/CIP1\/SDI1 in differentiating human leukemic cells.","volume":"95","author":"Schwaller","year":"1995","journal-title":"J Clin Invest."},{"key":"2020021222112038400_B11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.onc.1203384","article-title":"H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.","volume":"19","author":"Delgado","year":"2000","journal-title":"Oncogene."},{"key":"2020021222112038400_B12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1600-0609.2000.065004221.x","article-title":"Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1\/CIP1 in human immature leukemic cells.","volume":"65","author":"Nanjokat","year":"2000","journal-title":"Eur J Haematol."},{"key":"2020021222112038400_B13","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood.V93.12.4059","article-title":"DNA methylation.","volume":"93","author":"Singal","year":"1999","journal-title":"Blood."},{"key":"2020021222112038400_B14","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood.V94.7.2452.419k23_2452_2460","article-title":"ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.","volume":"94","author":"Asimakopoulos","year":"1999","journal-title":"Blood."},{"key":"2020021222112038400_B15","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4b and p16INK4a characterize the major types of hematological malignancies.","volume":"57","author":"Herman","year":"1997","journal-title":"Cancer Res."},{"key":"2020021222112038400_B16","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V91.8.2985.2985_2985_2990","article-title":"Methylation of the p15 (INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.","volume":"91","author":"Quesnel","year":"1998","journal-title":"Blood."},{"key":"2020021222112038400_B17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/90.14.1072","article-title":"Effect of p21WAF1\/CIP1 expression on tumor progression in bladder cancer.","volume":"90","author":"Stein","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"2020021222112038400_B18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21WAF1 genes are associated with aggressive variants of mantle cell lymphomas.","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood."},{"key":"2020021222112038400_B19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/excr.1998.4319","article-title":"Transcriptional regulation of the p21 (WAF1\/CIP1) gene.","volume":"246","author":"Gartel","year":"1999","journal-title":"Exp Cell Res."},{"key":"2020021222112038400_B20","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1182\/blood.V84.11.3781.bloodjournal84113781","article-title":"Absence of WAF1 mutations in a variety of human malignancies.","volume":"84","author":"Shiohara","year":"1994","journal-title":"Blood."},{"key":"2020021222112038400_B21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2141.2001.02764.x","article-title":"Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome.","volume":"113","author":"Roman","year":"2001","journal-title":"Br J Haematol."},{"key":"2020021222112038400_B22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol."},{"key":"2020021222112038400_B23","first-page":"163","article-title":"Spanish acute lymphoblastic leukemia trials.","volume":"5","author":"Ortega","year":"1998","journal-title":"Int J Pediatr Hematol Oncol."},{"key":"2020021222112038400_B24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/978-3-642-71960-8_101","article-title":"Treatment of high-risk acute lymphoblastic leukemia: preliminary results of the protocol PETHEMA ALL-93.","volume-title":"Acute Leukemias VII: Experimental Approaches and Novel Therapies.","author":"Ribera","year":"1998"},{"key":"2020021222112038400_B25","first-page":"222","article-title":"Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia: results of a prospective multicenter randomized trial (PETHEMA ALL-89).","volume":"83","author":"Ribera","year":"1998","journal-title":"Haematologica."},{"key":"2020021222112038400_B26","first-page":"586","article-title":"Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate-risk acute lymphoblastic leukemia: final results of the prospective randomized PETHEMA ALL-89 TRIAL.","volume":"86","author":"Ortega","year":"2001","journal-title":"Haematologica."},{"key":"2020021222112038400_B27","first-page":"3290","article-title":"Inhibition of the interferon-\u03b3\/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.","volume":"60","author":"Chen","year":"2000","journal-title":"Cancer Res."},{"key":"2020021222112038400_B28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1992.tb06463.x","article-title":"Diagnosis of acute promyelocytic leukemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts.","volume":"82","author":"Borrow","year":"1992","journal-title":"Br J Haematol."},{"key":"2020021222112038400_B29","first-page":"391","article-title":"Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias.","volume":"9","author":"Cimino","year":"1995","journal-title":"Leukemia."},{"key":"2020021222112038400_B30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V87.3.1075.bloodjournal8731075","article-title":"Consistent amounts of acute leukemia-associated p190BCR\/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.","volume":"87","author":"Saglio","year":"1996","journal-title":"Blood."},{"key":"2020021222112038400_B31","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/sj.onc.1203956","article-title":"Loss of p21WAF1\/CIP1 accelerates Ras oncogenesis in a transgenic\/knockout mammary cancer model.","volume":"19","author":"Adnane","year":"2000","journal-title":"Oncogene."},{"key":"2020021222112038400_B32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers.","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science."},{"key":"2020021222112038400_B33","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood.V82.10.3163.3163","article-title":"Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.","volume":"82","author":"Wada","year":"1993","journal-title":"Blood."},{"key":"2020021222112038400_B34","first-page":"1113","article-title":"Loss of p73 gene expression in leukemias\/lymphomas due to hypermethylation.","volume":"94","author":"Kawano","year":"1999","journal-title":"Blood."},{"key":"2020021222112038400_B35","first-page":"262","article-title":"Mechanism for inactivation of the kip family cyclin-dependent kinase inhibitor genes in gastric cancer cells.","volume":"60","author":"Shin","year":"2000","journal-title":"Cancer Res."},{"key":"2020021222112038400_B36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1126\/science.277.5334.1996","article-title":"Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target of p21WAF1.","volume":"277","author":"Chuang","year":"1997","journal-title":"Science."},{"key":"2020021222112038400_B37","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","article-title":"CpG island methylator phenotype in colorectal cancer.","volume":"96","author":"Toyota","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021222112038400_B38","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood.V97.9.2823","article-title":"Methylation profiling in acute myeloid leukemia.","volume":"97","author":"Toyota","year":"2001","journal-title":"Blood."},{"key":"2020021222112038400_B39","first-page":"2364","article-title":"Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia.","volume":"95","author":"Stock","year":"2000","journal-title":"Blood."},{"key":"2020021222112038400_B40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9440(10)61686-0","article-title":"Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16 and p27.","volume":"159","author":"Sanchez-Beato","year":"2001","journal-title":"Am J Pathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/7\/2291\/1682050\/2291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/7\/2291\/1682050\/2291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T03:14:26Z","timestamp":1581563666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/7\/2291\/106720\/5-CpG-island-hypermethylation-is-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.7.2291","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4,1]]}}}